🔍
Search Results - michael+kornberg
1
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Novel Therapeutic Drug for Multiple Sclerosis
INVENTION NOVELTY This molecule, through its action on a unique target that is different from current therapeutic treatments for MS, has both immunosuppressive and neuromodulatory properties that will better prevent the progression of MS and repair the neuronal damage caused by the immune cells in MS. Currently, there are no MS drugs in the market...
Published: 5/9/2024
|
Inventor(s):
Paul Kim
,
Michael Kornberg
,
Peter Calabresi
,
Solomon Snyder
Keywords(s):
Chronic Inflammatory Diseases
,
CNS and Neurological Disorders
,
Disease Indication
,
Multiple Sclerosis
,
Multiple Sclerosis (MS)
,
Neurodegeneration
,
Novel
,
Predicted Novelty
,
Small Molecules
,
Therapeutic Matter
,
Therapeutic Substance
,
Therapeutics
Category(s):
Clinical and Disease Specializations
,
Clinical and Disease Specializations > Autoimmunity
,
Technology Classifications > Therapeutic Modalities > Small Molecules
,
Clinical and Disease Specializations > Inflammation
,
Clinical and Disease Specializations > Neurology
,
Technology Classifications > Therapeutic Modalities
,
Clinical and Disease Specializations > Inflammation > Chronic Inflammatory Diseases
,
Clinical and Disease Specializations > Neurology > Multiple Sclerosis
,
Clinical and Disease Specializations > Neurology > Neurodegeneration
,
Clinical and Disease Specializations > Immunology
JHTV Home
|
Search
|
Login/Subscribe
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by
Inteum